Active Cancer Biomarkers Grants
| PI Name |
Organization - Company |
Title | Major Program / Research Group | FOA |
|---|---|---|---|---|
| Chung, Fung-Lung | Georgetown University | gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention | PAR-15-307: Translational Studies on Adducts for Cancer Risk Identification and Prevention | |
| Riegel, Anna Tate | Georgetown University | (PQ6) Molecular Mechanisms Driving Benign to Malignant Transitions in Breast Cancer | RFA-CA-15-008: Research Answers to NCI's Provocative Questions | |
| Lin, Jia-Ren | Harvard Medical School | Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images | PAR-21-285: NCI Research Specialist (Laboratory-based Scientist) Award | |
| Schabath, Matthew B | H. Lee Moffitt Cancer Ctr & Res Inst | Moffitt Imaging Biomarker VAlidation Center | Early Detection Research Network, EDRN Clinical Validation Center | RFA-CA-14-015: The Early Detection Research Network: Clinical Validation Centers |
| Permuth, Jennifer B | H. Lee Moffitt Cancer Ctr & Res Inst | Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology | PA-18-484: NIH Research Project Grant | |
| Hirsch, Fred R | Icahn School Of Medicine At Mount Sinai | Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses | COVID Serology | RFA-CA-20-038: Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence |
| Brennan, Paul Joseph | International Agency For Res On Cancer | PROMINENT - IARC | ||
| Almonte, Maribel | International Agency For Res On Cancer | Development and clinical validation of a multi-type HPV E6/E7 oncoprotein test for cervical cancer screening and triage in low- and middle-income countries | RFA-CA-15-001: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UH2/UH3) | |
| Wei, Chia-Lin | Jackson Laboratory | Advancing Ultra Long-read Sequencing and Chromatin Interaction Analyses for Chromosomal and Extrachromosomal Structural Variation Characterization in Cancer | RFA-CA-19-020: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research | |
| Bettegowda, Chetan | Johns Hopkins University | Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid | PA-16-160: NIH Research Project Grant | |
| Umbricht, Christopher B | Johns Hopkins University | Discovery and validation of early molecular breast cancer risk markers in benign breast disease | PA-16-160: NIH Research Project Grant | |
| Wang, Tza-Huei | Johns Hopkins University | Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women | PA-20-185: NIH Research Project Grant | |
| Chan, Daniel Wanyui | Johns Hopkins University | Clinical and Analytical Validation of Cancer Biomarkers | Early Detection Research Network, EDRN Biomarker Reference Lab | RFA-CA-14-016: The Early Detection Research Network: Biomarker Reference Laboratories |
| Meltzer, Stephen J | Johns Hopkins University | Facile screening for esophageal cancer in LMICs | RFA-CA-15-024: Cancer Detection, Diagnosis, and Treatment Technologies for Global Health (UG3/UH3) | |
| Papadopoulos, Nickolas | Johns Hopkins University | Earlier Detection of Cancers using Non-Plasma Based Liquid Biopsies | Liquid Biopsy Consortium | RFA-CA-17-029: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment |